Aytu Biopharma, Inc

Ownership Transactions Reported by 13 Insiders

Symbol
AYTU on Nasdaq
Location
7900 E. Union Avenue, Suite 920, Denver, CO

Insiders trading volume in the past year

Aytu Biopharma, Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Nantahala Capital Management, LLC 10%+ Owner $7.22M +$6M +491% Jun 6, 2025
Armistice Capital, Llc Director $5.02M Mar 20, 2021
Christopher Brooke Chief Operating Officer $2.18M Aug 11, 2023
Joshua R. Disbrow Chief Executive Officer, Director $487K +$119K +32.5% Oct 3, 2025
K. Oki Chief Financial Officer $355K Aug 11, 2023
Gary Cantrell Director $307K Dec 21, 2022
Jarrett Disbrow Chief Business Officer $145K +$25K +20.9% Oct 3, 2025
Ryan J. Selhorn Chief Financial Officer $117K Oct 3, 2025
Greg Pyszczymuka Chief Commercial Officer $84.8K Oct 3, 2025
Carl Dockery Director $48K Oct 3, 2025
Vivian H. Liu Director $46.6K Oct 3, 2025
Abhinav Jain Director $45.8K Oct 3, 2025
John Donofrio Jr. Director $32.3K Oct 3, 2025

Recent Insider Transactions by Companies or Individuals for Aytu Biopharma, Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.